References
- Assady S, Maor G, Amit M et al. Insulin production by human embryonic stem cells. Diabetes 2001;50:1691–7.
- Hon Y, Rulifson IC, Tsai BC et al. Growth inhibitors promotedifferentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA 2002;99:16105–10.
- Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonicstem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. 7 Clin Invest 2001;108: 407–14.
- Reubinoff BE, Itsykson P, Turetsky T et al. Neural progenitorsfrom human embryonic stem cells. Nat Biotechnol 2001;19:1134–40.
- Zhang SC, Wernig M, Duncan ID et al. In vitro differentiation oftransplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129–33.
- Bjorklund LM, Sanchez-Pernaute R, Chung S et al. Embryonicstem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 2002;99:2344–9.
- Zheng T, Steindler DA, Laywell ED. Transplantation of an indigenous neural stem cell population leading to hyperplasia and atypical integration. Cloning Stem Cells 2002;4:3–8.
- Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl y Med 2001;344:710–9.
- Bonini C, Ferrari G, Verzeletti S et al. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 1997;276:1719–24.
- Muller M, Fleischmann BK, Selbert S et al. Selection of ventricular-like cardiomyocytes from ES cells in vitro. FASEB 2000;14:2540–8.
- Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. 7 Clin Invest 1996;98:216–24.
- Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective abla-tion of human embryonic stem cells expressing a 'Suicide' gene. Stem Cells 2003;21:257–65.
- Fareed MU, Moolten FL. Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand - a fail-safe protection against cellular misbehavior. Gene Ther 2002;9:955–62.
- Gray JA, Grigoryan G, Virley D et al. Conditionally immorta- lized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation. Cell Transplant 2000;9:153–68.
- Dufayet de la Tour D, Halvorsen T, Demeterco C et al. Beta-celldifferentiation from a human pancreatic cell line in vitro and in vivo. Mol Endocrinol 2001;15:476–83.
- The European Agency for the Evaluation of Medicinal Products(EMEA), Committee for proprietary medicinal products (CPMP): Note for guidance on the quality, preclinical and clinical aspects of gene transfer medicinal products, vol. CPMP/ BWP/3088/99, 2001. EMEA. www.emea.eu.int/pdfs/human/ bwp/308899en.pdf
- The European Agency for the Evaluation of Medicinal products(EMEA), Committee for proprietary medicinal products (CPMP): Points to consider on the manufacture and quality control of human somatic cell therapy medicinal products, vol. CPMP/BWP/41450/98, 2001. EMEA. www.emea.eu.int/pdfs/ human/bwp/4145098en.pdf
- Li E, Bestor TH, Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992; 69:915–26.
- Giard DJ, Aaronson SA, Todaro GJ et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. 7 Natl Cancer Instit 1973;51:1417–23.
- Nicklas W, Weiss J. Survey of embryonic stem cells for murineinfective agents. Comp Med 2000;50:410–1.
- Bahnemann R, Jacobs M, Karbe E et al. RITA - Registry ofIndustrial Toxicology Animal-data - guides for organ sam-pling and trimming procedures in rats. Exp Toxicol Pathol 1995;47:247–66.
- Romeis B. Mikroskopische Technik, 17th edn. Munich, Vienna, Baltimore: Urban and Schwarzenberg, 1989.
- Liu X, Wu H, Loring J et al. Trisomy eight in ES cells is a common potential problem in gene targeting and interferes with germ line transmission. Dev Dyn 1997;209:85–91.
- WHO Expert Committee on Biological Standardization, vol. 878. Geneva: World Health Organization, 1998.
- van Weerden WM, Romijn JC, de Ridder CMA et al. Frequentoccurrence of spontaneous rumors in NMRI athymic nude mice. In: Arnold W, Kopf-Maier P, Micheel B, editors. Immunodeficient animals. models for cancer research, vol. 51. Karger: Contrib Oncol. Basel, 1996: 41–4.
- Sharkey FE, Fogh J. Considerations in the use of nude mice forcancer research. Cancer Metastasis Rev 1984;3:341–60.
- Sharkey FE, Fogh J. Incidence and pathological features of spontaneous rumors in athymic nude mice. Cancer Res 1979;39:833–9.
- Gershwin ME, Ohsugi Y, Castles JJ et al. Anti-mu induces lymphoma in germfree congenitally athymic (nude) but not in heterozygous (nu/ +) mice. 7 Immunol 1983;131: 2069–73.
- Mohr U. International classification of rodent tumors. the mouse. BerlinHeidelberg: Springer Verlag, 2001: 234–5.
- Hogan B, Beddington R, Costantini F et al. Manipulating the mouse embryo, 2nd edn. New York: Cold Spring Harbor Laboratory Press, 1994.
- Takahashi K, Mitsui K, Yamanaka S. Role of ERas in promotingtumour-like properties in mouse embryonic stem cells. Nature 2003;423:541— 5.
- Pleasure SJ, Page C, Lee VM. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. y Neurosci 1992;12: 1802–15.
- Greco 0, Dachs GU. Gene directed enzyme/prodrug therapy ofcancer: historical appraisal and future prospectives. y Cell Physiol 2001;187: 22— 36.
- Freeman SM. Suicide gene therapy. Adv Exp Med Biol 2000;465:411— 22.
- Moolten FL. Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther 1994;1:279— 87.
- Kirschstein R, Skirboll L. Stem cells. scientific progress and futureresearch directions. National Institutes of Health, Department of Health and Human Services, 2001. www.stemcells.nih.gov/ stemcell/scireportasp
- Food and Drug Administration, Center for Biologics Evaluation and Research, 27th Meeting of the Biological Response Modifiers Advisory Committee; 2000, July 13–14; Gaithersburg, Maryland. www.fda.gov/ohrms/dockets/ac/cber00.htm
- Erdo F, Buehrle C, Blunk J et al. Host-dependent tumorigenesis of embryonic stem cell transplantation in experimental stroke. y Cereb Blood Flow Metab 2003;23:780–5.
- Bonfil RD, Vinyals A, Bustuoabad OD et al. Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumor-igenicity. Int y Cancer 1994;58:233— 9.
- Pretlow TG, Delmoro CM, Dilley GG et al. Transplantation ofhuman prostatic carcinoma into nude mice in Matrigel. Cancer Res 1991;51:3814–7.
- Fridman R, Sweeney TM, Zain M et al. Malignant transforma-tion of NIH-3T3 cells after subcutaneous co-injection with a reconstituted basement membrane (matrigel). Int y Cancer 1992;51:740–4.
- Noel A, De Pauw-Gillet MC, Purnell G et al. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br7 Cancer 1993;68:909–15.
- Topley P, Jenkins DC, Jessup EA et al. Effect of reconstituted basement membrane components on the growth of a panel of human tumour cell lines in nude mice. Br y Cancer 1993;67: 953–8.
- Fridman R, Kibbey MC, Royce LS et al. Enhanced rumor growthof both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel. 7 Natl Cancer Inst 1991;83:769— 74.